ZYBT NASDAQ
Zhengye Biotechnology Holding Limited
1W: -6.9%
1M: -25.1%
3M: +75.3%
YTD: +8.0%
1Y: -49.8%
$1.24
-0.02 (-1.59%)
Weekly Expected Move ±7.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$493M
-1.3% ▼
3Y CAGR: +3.5%
Total Liabilities
$141M
-12.4% ▼
3Y CAGR: +3.6%
Shareholders Equity
$284M
+4.1% ▲
3Y CAGR: +2.0%
Cash & Investments
$20M
+22.9% ▲
3Y CAGR: +47.2%
Total Debt
$86M
-3.8% ▼
3Y CAGR: +42.3%
Net Debt
$68M
-9.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| — Assets — | ||||
| Cash | $6M | $10M | $15M | $19M |
| Short-Term Investments | $0 | $0 | $1M | $1M |
| Cash & ST Investments | $6M | $10M | $16M | $20M |
| Net Receivables | $102M | $134M | $99M | $89M |
| Inventory | $44M | $55M | $58M | $58M |
| Other Current Assets | $11M | $12M | $24M | $2K |
| Total Current Assets | $165M | $214M | $206M | $178M |
| Property, Plant & Equip. | $255M | $284M | $271M | $255M |
| Goodwill & Intangibles | $12M | $19M | $16M | $23M |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Other Non-Current Assets | $13M | $2M | $7M | $27M |
| Total Non-Current Assets | $280M | $305M | $294M | $316M |
| Total Assets | $445M | $520M | $500M | $493M |
| — Liabilities — | ||||
| Accounts Payable | $78M | $79M | $46M | $43M |
| Short-Term Debt | $30M | $55M | $80M | $82M |
| Deferred Revenue | $4M | $5M | $4M | $4M |
| Other Current Liabilities | $0 | $0 | $0 | $3M |
| Total Current Liabilities | $126M | $152M | $150M | $136M |
| Long-Term Debt | $0 | $10M | $10M | $5M |
| Other Non-Current Liab. | $816K | $590K | $393K | $0 |
| Total Non-Current Liabilities | $816K | $11M | $10M | $5M |
| Total Liabilities | $126M | $163M | $161M | $141M |
| — Equity — | ||||
| Common Stock | $8K | $8K | $8K | $8K |
| Retained Earnings | $42M | $66M | $38M | $48M |
| Accumulated OCI | $22M | $28M | $31M | $33M |
| Total Stockholders Equity | $267M | $296M | $273M | $284M |
| Total Liabilities & Equity | $445M | $520M | $500M | $493M |
| — Key Metrics — | ||||
| Total Debt | $30M | $65M | $90M | $86M |
| Net Debt | $24M | $55M | $75M | $68M |
| Total Investments | $0 | $0 | $1M | $1M |